Webinar Objectives: 

Webinar Objectives: 

Webinar Objectives: 

Webinar Objectives: 

•  Shared case studies are a learning opportunity for all. Our subject matter experts will be reviewing HLA antibody analysis on the MATCH IT! Antibody software using informative case studies and software tools.

Speakers: Erik Chatroop, MS, MLS(ASCP)^CM, CHS(ACHI) and Lindsay Murdock, MS, CHT(ABHI), MLS(ASCP)^CM

Webinar Summary: 

Using informative case studies and software tools, our subject matter experts will be reviewing HLA typing. Learn more about what makes MIA FORA NGS software and assays unique.

Speakers: Amelia Chen

Webinar Summary: 

Our subject matter experts will be reviewing HLA antibody analysis on MATCH IT! Antibody software using informative case studies, software tools, and interactive polls.

Speakers: K. Kelly Cousins, BS, CHT (ABHI) and Jean L. Heneghan, MS, CHS(ABHI)

Webinar Objectives: 

• HLA antibody analysis on MATCH IT! Antibody v1.5.1 software using informative case studies and software tools

Speakers: Lindsay Murdock, MS, CHT(ABHI), MLS(ASCP) ^CM  and Erik Chatroop, MS, MLS(ASCP)^CM, CHS(ACHI)

Webinar Objectives: 

• Writing procedures and work instructions
• Quality managements
• Standards of laboratory practice
• Test performance appraisal and validation

Speaker: Dr. Marco Andreani Ph.D. ; Dr. Walter Herczyk CHS(ACHI) MT (ASCP)

Webinar Objectives:

• Organ transplantation
• Allogeneic hematopoietic stem cell transplantation
• Single donor platelet transfusion for alloimmunized patients
• HLA and disease associations

Speaker: Dr. Sunil Daga MBBS MRCP PhD

Webinar Objectives 

• Clinical Histocompatibility Testing for Xenotransplantation: What We Have and What We Need
• Post-transplant Rejection Diagnostics:  a Bermuda Triangle between HLA Specialists, Nephrologists and Pathologists
• The Next Steps in the Routine Diagnostic Implementation of Non-HLA Antibody Testing
• The Role of HLA and Non-HLA Antibody Burden in the Outcome of Pediatric Kidney Transplantation

Speakers: Sam Ho, Maarten Naesens, Carrie Butler, Patrizia Comoli

Webinar Objectives 

• Unlocking the Power of PIRCHE-II: Exploring the Role of HLA Mismatch in Risk Stratification
• The Use of PIRCHE in Stem Cell Transplantation
• The HLA Eplet Registry. New Design, New Tools and Future Directions
• Shaping the NEXT GENERATION of MATCH IT!^® Software

Speakers: Bethany Dale, Meenakshi Singh, Massimo Mangolia, Alisa Rantanen

Webinar Objectives

• Best Practices for Antibody Testing
• Canadian Genome Project
• Virtual Crossmatch: How and Why?, US Perspective
• Virtual Crossmatch: How and Why?, Eurotransplant
• Virtual Crossmatch:  How and Why, Down Under

Speakers: Annette Jackson, Karen Sherwood, Paul Keown, Luis Hidalgo, Cynthia Kramer, Rhonda Holdsworth

Obiettivi el corso:

• Nomenclatura
• HLAi & UKLKSS
• Allocazione
• Post-trapianto

Oratore: Miriam Manook, MBChB, MRCS (Ed), PhD

Obiettivi el corso:

• Effetto della variazione del segnale peptide HLA di classe I sull'espressione di HLA-E

Oratore: Miriam Manook, MBChB, MRCS (Ed), PhD

Webinar Objectives: 

• Sensitivity of antibody detection assays
• Epitope of structure of HLA gene products
• Relationships of HLA epitopes and sequence
•  Analysis of HLA antibodies in patients
• Dynamics of HLA antibody production

Speaker: Tiffany Bratton, PhD

Webinar Objectives: 

• Complement-dependent cytotoxicity assay,
  flow cytometry, & ELISA
• Complement and antiglobulin reagents Molecular genetics

Speaker: Michael D. Gautreaux, PhD, FACHI

Webinar Objectives: 

• HLA complex & nomenclature
• Genetics of the HLA complex
• Physical and antigenic structure & functioning of HLA gene products

Speaker: Gizem Turmer, MD

Objectif du cours:

• Nomanclature
• HLAi & UKLKSS
• Allocation
• Post-transplantation

Orateur: Miriam Manook, MBChB, MRCS (Ed), PhD

Objectif du webinaire

• Effet de la variation du peptide signal HLA de classe I sur l'expression HLA-E

Speaker: Dr. Mary Carrington, Center for Cancer Research, Bethesda, ML

Webinar Objective:

• LEARNing is fun in a new way when you complete this virtual intensive, transfusion medicine investigation.

Webinar Objectives:

• LEARNing is fun in a new way when you complete this virtual intensive, transplant medicine investigation.

Ziele des Kurses:

• Nomenklatur
• HLAi & UKLKSS
• Organzuteilung
• Post-Transplantation

Referent: Miriam Manook, MBChB, MRCS (Ed), PhD

Objetivos del curso:

• Nomenclatura
• HLAi y UKLKSS
• Asignación
• Post-trasplante

Oradora: Miriam Manook, MBChB, MRCS (Ed), PhD

Webinar-Ziele:

• Auswirkung von HLA-Klasse-I-Signalpeptid-Variationen auf die HLA-E-Expression

Vortragende: Dr. Mary Carrington, Center for Cancer Research, Bethesda, ML 

Efecto de la variación del péptido señal HLA Clase I en la expresión HLA-E con la Dra. Mary Carrington, Centro de Investigación del Cáncer, Bethesda, ML

Webinar Objectives:

•  Learn more about PIRCHE
• How PIRCHE can help you see beyond limits of transplant diagnostics.

Speaker: Massimo Mangiola, Ph.D., A(ACHI)

Webinar Objecties:

• Understand the Clinical relevance of NK (natural killer) cells Immunogenetics

Speaker: Dr. Rajalingam Raja, UCSF, USA

Webinar Objectives:

• HLA antibody analysis on the NEW MATCH IT! Antibody v1.5 software using informative case studies and software tools

Speakers: K. Kelly Cousins, BS, CHT (ABHI), Jean L. Heneghan, MS, CHS (ABHI)

Webinar Objective:

• Effect of HLA Class I Signal Peptide variation on HLA-E Expression 

Speaker: Dr. Mary Carrington, Center for Cancer Research, Bethesda, ML

Webinar Objectives:

• Nomenclature
• HLAi & UKLKSS
• Allocation
• Post-transplant

Speaker: Miriam Manook, MBChB, MRCS (Ed), PhD

Webinar Objectives:
• Organize and categorize transfusion complications given the reported signs and symptoms.
• Discover how laboratory findings correlate with the clinical signs and symptoms of transfusion complications.
• Compare and contrast acute and delayed transfusion reactions.
• Apply how to define the adverse complications of transfusion in example case studies.

Speaker: Jayanna Slayten, MS, MT(ASCP)SBB^CM

Webinar Objectives: 

• Clear and Unambiguous Typing Results: MIA FORA NGS Expanded Coverage
• Anti-HLA Antibody Strength & Crossmatch: Is there a Correlation?
• Enhancing Antibody Analysis for the Benefit of Patient Outcomes using PIRCHE Technology
• Where Do We Go from Here? The Present and Future of Non-HLA.

Speakers: Tiffany K Bratton, PhD, DABCC, FAACC, FACHI, Alin Girnita, MD, PhD, D(ACHI), Bethany L. Dale, PhD, Michelle Hickey, PhD, D(ACHI)

Webinar Objectives:

• HLA-DQ Antibodies in Solid Organ Transplantation

Speakers: Anat Roitberg-Tambur, DMD, PhD

Webinar Objectives: 

• The Eurotransplant Acceptable Mismatch Program
• How HLA epitope knowledge may benefit highly sensitized patients
• HLA-specific memory B cells: possible use for delisting and desensitization strategies
• Highly sensitized patients are disadvantaged by the presence of denatured HLA in Luminex HLA single antigen testing
• How implementing two SAB vendors can help patients

Speakers: Annette Jackson, Sebastiaan Heidt, Suzanne Bezstarosti, Gonca Karahan, Richard Battle, Alin Girnita 

Webinar Objectives: 

• The Genome Canada Consortium on Precision Medicine in Renal Transplantation
• The Evolution and Revolution in NGS
• Getting the basic building blocks rights- The impact of NGS based HLA typing on our clinical practice
• Definition of immunogenic and non-immunogenic HLA epitopes
• Updates from the HLA- DQ antibody component of the International Histocompatibility Workshop

Speakers: Paul Keown, Karen Sherwood, Sujatha Krisnakumar, Dolly Rose, Cynthia Kramer, Anat Tambur

Webinar Objectives: 

• What's in your toolbox? Experiences with LIFECODES ID assays
• What's in your toolbox? Experiences with LIFECODES LSA and C3d assays
• Non-HLA: A voyage into the unknown
• Clinical Relevance of Non-HLA Antibody Burden in Kidney Transplantation
• Non-HLA antibody panel: from bench to bedside

Speakers: Mike Gautreaux, Brett Loehmann, Bryan Ray, Alek Senev, Carrie Butler

Webinar Objectives: 

• Hematopoietic stem cell transplantation from unrelated donors in Germany
• Structures, Figures, Matching Guidelines, and Outcomes

Speaker: Dr. Joannis Mytilineos

Webinar Objectives: 

• HLA Matching Paradigms in Allogeneic HSCT

Speaker: Dr. Meenakshi Singh, Advanced center for Treatment, Research and Education in Cancer, Navi Mumbai, India

Webinar Objectives:

• Overview of single antigen analysis technology
• Walk through of an interactive case study

Speakers: K. Kelly Cousins, Jean L. Heneghan

Webinar Objectives: 

• Methods to obtain access to CCP
• NYC & the Covid-19 Pandemic
• CUIMC CCP Clinical Trials
• Impacts on Transfusion Service operations

Speakers: Joseph (Yossi) Schwarts

Webinar Objectives:

• Advantages of Multi-Assay Analysis: Resolving Discrepancies between Solid Phase Immunoassays
• Non-HLA antibody panel discovery, development, and validation: From bench to bedside
• Redesigning HLA Compatibility: Does it work and are we ready?

Speaker: Julie Houp, MS CHS  Carrie L. Butler, Ph.D.  Massimo Mangiola, Ph.D. D(ACHI)

Webinar Objectives: 

• Overview of single antigen analysis technology
• Walk through of an interactive case study

Speakers: K. Kelly Cousins, Jean L. Heneghan

Webinar Objectives: 

• Overview of single antigen analysis technology
• Walk through of an interactive case study

Speakers: K. Kelly Cousins, Jean L. Heneghan

Webinar Objectives: 

• Transplanting sensitized candidates: new options for overcoming DSA barriers

Speaker: Annette Jackson

Webinar Objectives: 

• Diagnosis of antibody-meditated rejection in 2021: antibodies, biopsies, and molecules

Speaker: Michael Mengel

Webinar Objectives: 

• Lab week Case Studies with Lifecodes LSA

Speaker: Dave Pinelli 

Webinar Objectives: 

• Overview of single antigen analysis technology
• Walk through of an interactive case study

Speakers: K. Kelly Cousins, Jean L. Heneghan

Webinar Objectives: 

• Overview of single antigen analysis technology
• Walk through of an interactive case study

Speakers: K. Kelly Cousins, Jean L. Heneghan

Webinar Objectives: 

• Overview of single antigen analysis technology
• Walk through of an interactive case study

Speakers: K. Kelly Cousins, Jean L. Heneghan

Webinar Objectives: 

• Identify the genetic mechanism for the inheritance of the ABH blood group antigen, including the Bombay phenotype
• Differentiate the transferases and biochemical structures of the ABH antigens
• Evaluate the characteristics of and relationship between antigens and antibodies in the ABO system
• Identify lectin reagents that show ABO blood groups specifically
• Assess the effects of disease and age on production of ABO antigens and antibodies
• Classify the A and B antigens into subgroups, including serologic characteristics, number of antigen site and frequency in the population

Speaker: LeeAnn Walker, MEd, MT(ASCP)SBB